Controlled release reduces dose frequency and helps steady exposure. RL/RS & NE grades tune permeability so you can target hours-long delivery without pH dependence.
Key benefits
Features that matter
Set release rate with RL/RS ratio
pH-independent release profiles
Aqueous dispersions available
Strong, flexible films
Pellets, tablets, mini-tabs
Scales cleanly to production
Solution series
Sustained release
DRUGCOAT SERIES
MONOGRAPHS
PHYSICAL FORM
DISSOLUTION PROPERTIES
DRUGCOAT RL 100
USP/NF: Ammonio Methacrylate Copolymer, Type A Ph. Eur.: Ammonio Methacrylate Copolymer, Type A
Granules
pH-independent swelling
DRUGCOAT RL PO
Powder
DRUGCOAT RL 12.5
Organic Solution 12.5%
DRUGCOAT RS 100
USP/NF: Ammonio Methacrylate Copolymer, Type B Ph. Eur.: Ammonio Methacrylate Copolymer, Type B
First in India to get EXCiPACT international GMP Certified
2024
US DMF Available
Registered in US Drug Master File.
2014
ISO 9001 Certified
Certified for quality management.
2005
WHO cGMP Compliance
Complies with WHO cGMP standards
2005
HALAL Certified
HALAL certified excipients.
FAQs
A few questions answered
What is a Sustained Release Formulation?
It refers to a design strategy that ensures prolonged release of drugs through a sustained release drug delivery system, reducing dosing frequency and improving compliance.
How are Sustained Release Tablets Formulated?
They are created by embedding active ingredients in matrices or applying coatings of sustained release polymers to achieve steady delivery.
What Are the Benefits of Sustained Release Tablets?
They provide reduced dosing frequency, steady therapeutic levels, and improved adherence, making them an ideal therapeutic tablet solution.
How Are Polymers Utilized in Sustained Release Tablet Formulation?